Uses of Eslady

Eslady is indicated for the treatment of disorders related to progesterone reduction, infertility due to luteal insufficiency and endometriosis,... So how is Eslady used? Let's find out the necessary information about the drug Eslady through the article below.

Information about the drug Eslady:
Ingredients: Dydrogesterone 10mg. Dosage form: Film coated tablets. Packing: 2 blisters x 10 tablets/box; 3 blisters x 10 tablets/box. Classification: Endocrine drugs – Progestogens. Legal group: ETC prescription drugs. Manufacturer: TW Mediplantex Pharmaceutical Joint Stock Company.

Indications:
Disorders related to low progesterone (premenstrual syndrome, irregular menstruation due to disorder or failure to ovulate, benign breast diseases, breast tenderness and perimenopause, .. .). Menopause (treatment with estrogen). Infertility due to luteal insufficiency. Threatened miscarriage or recurrent miscarriage (due to luteal insufficiency). Endometrial optimism . Dosage - usage:
Treatment of dysmenorrhea: 10mg x 2 times/day, from day 5-25 of the menstrual cycle. Treatment of endometriosis: 10mg x 2-3 times/day, from day 5-25 of the menstrual cycle, or drink continuously. Treatment of bleeding due to dysfunction: If you want to stop bleeding, use a dose of 10mg x 2 times/day in combination with an oestrogen once/day, for 5-7 days. In the case of bleeding prevention, the dose is 10mg x 2 times/day in combination with an oestrogen 1 time/day, from day 11-25 of the menstrual cycle. Treatment of secondary amenorrhea: Use 1 oestrogen 1 time / day, from day 1-25, combined with dydrogesterone 10mg x 2 times / day, from day 11-25 of the menstrual cycle. Treatment of premenstrual syndrome / irregular menstrual cycle: 10mg x 2 times / day, from day 11-25 of the menstrual cycle. Treatment of infertility: 10mg/day from day 14-25 of the cycle, treat at least 6 consecutive cycles. Treatment of threatened miscarriage: 40mg at first, then 10mg every 8 hours until symptoms subside. Treatment of recurrent miscarriage: 10mg x 2 times/day until the 20th week of pregnancy. Treatment of Postmenopausal Disorders (HRT): In combination with continuous or cyclic estrogen therapy: Take 10-20mg of dydrogesterone/day for the last 12-14 days of each menstrual cycle.

At therapeutic doses, Eslady is well tolerated. However, during the use of Eslady, patients may still experience side effects such as:
Common (≥1/100, <1/10): Headache, nausea, menstrual disorders (bleeding) uterus, menorrhagia, amenorrhea, dysmenorrhea and irregular menstruation), pain, breast tenderness. Uncommon (≥ 1/1000, < 1/100): Depression, dizziness, vomiting, abnormal liver function (jaundice, fatigue, malaise, lower abdominal pain), atopic dermatitis (rash, itching, rash) and weight gain. Rare (≥ 1/10000, < 1/1000): Drowsiness, angioedema, edema, Progestogen-dependent increase in tumor size and hemolytic anemia.

Contraindications:
Progesterone-related tumor. Vaginal bleeding Thromboembolism, embolism. Liver disease or severe liver failure. Breast cancer. Pregnancy test. Hypersensitivity to the components of the drug. Children under 18. Note/Caution:
Liver function is severely damaged. Pregnant

Should not combine Eslady with the following drugs:
Anticonvulsants (Carbamazepine, Phenytoin, primidone, Phenobarbital); Barbiturates; Drug Griseofulvin; Rifabutine drug; Rifampicin drug. Use caution when combining Eslady with the following drugs:
Antidiabetic drugs (Insulin, metformin and sulfamide to lower blood sugar): Due to high doses of progestatif, it can cause diabetes. Need to self-monitor blood sugar and urine. The article has provided information on what Eslady medicine has, dosage and notes when using it. To ensure safety for your health and maximize the effectiveness of your treatment, you need to take Eslady exactly as directed by your doctor. Store Eslady medicine in a dry place and the temperature does not exceed 30 degrees C.